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Valuing Knowledge and the Knowledge of Values: Understanding GuidelineIncongruent Prescribing
Mitchell Levine, MD, MSc, and Jarold Cosby, BA, MA A n extensive number of practice guidelines have been published and promulgated to guide the behavior of health care providers. 1 Yet, the use of drugs in a guideline-incongruent manner continues to be an issue, 2 and the traditional research frontier seems only capable of making small gains in this area. 3 To better understand why we are observing disappointing drug utilization practices, we need to challenge the belief that noncompliance with optimal practices simply reflects a lack of informed judgment that can be corrected by educational interventions. A number of studies have demonstrated that a deficit in knowledge is not the only factor leading to guideline-incongruent prescribing. [4] [5] [6] More than two decades ago, Alfred Bandura introduced self-efficacy as a unifying theory of behavior change.
7 Self-efficacy is the self-perception that an individual has the ability to change his or her behavior. High self-efficacy is present when (1) an individual believes that a new behavior is worthwhile, (2) he or she has confidence in the ability to perform the new behavior, and (3) a reward is anticipated (outcome efficacy). The presence of these three features increases the likelihood that the behavior will be adopted. From this theory, one can see that knowledge alone is insufficient to change behavior, yet most interventions to improve physician prescribing behaviors focus on education as a means to achieving that goal. The dissemination of prescribing guidelines and continuing education events can be viewed as methods for bringing about behavior change through improving knowledge. Incorporating the self-efficacy model into our understanding of guideline-incongruent prescribing requires an appreciation of values since it is the value placed on a behavior that will influence whether it will occur. Policy makers and educators need to understand the nature of these value systems.
Self-efficacy theory would suggest that we must start thinking of guideline usage as an issue of knowledge and values. The interaction between physician knowledge and values creates a much more complex model of behavior than the traditional model where physician knowledge has been heralded as the overriding determinant of physician behavior.
Consider the following scenarios, where despite physicians being aware of the requisite medical knowledge, the clinical ideal is not consistently achieved:
• Physicians know that using anticoagulants in patients with atrial fibrillation could significantly reduce the risk of stroke, but there is underuse of this therapy in eligible patients. 8 • Physicians know that using an antibiotic is ineffective (and potentially harmful) in the management of a viral upper respiratory tract infection, but some physicians still use antibiotics in this manner. 9 • Physicians know that benzodiazepines should not be used chronically for nighttime sedation and that the practice of good sleep hygiene is a more appropriate alternative, but many physicians continue to renew indefinitely prescriptions used for nighttime sedation.
10
If the required knowledge for guideline-congruent behavior is known by the physician, what is the missing factor? Self-efficacy suggests that to improve physician adherence to prescribing guidelines, guideline proponents will need to attain an understanding of the values that influence a physician's willingness to change her or his prescribing behaviors.
In the three scenarios described above, physician value systems may explain the guideline-incongruent prescribing behaviors that continue to occur in the ab- sence of a knowledge deficit. The underuse of warfarin may reflect a physician's "personal" value that the benefits of stroke reduction are not worth either the risks of bleeding or the difficulties in monitoring and achieving a therapeutic dose (not worthwhile from the physician's perspective).
11 Physicians may provide an antibiotic prescription for a viral URTI to curtail an extended discussion with a patient who is persistent in a request for an antibiotic (reward for the physician). 6 Physicians who are chronically prescribing benzodiazepines for nighttime sedation may do so to achieve an outcome that their patients strongly desire, which the physicians feel they cannot achieve through other means (physician low confidence).
12 These are just a few proposed explanations for physician values that influence self-efficacy for various prescribing practices.
From the examples above, it should be evident that educational interventions and promulgation of clinical practice guidelines cannot address a variety of guideline-incongruent prescribing behaviors. To influence these practices, we need to obtain a better understanding of how specific values influence human behavior in the delivery of health care and design interventions that work with the value systems that are operating within practitioners and between practitioners and patients.
Consider the following as an illustration of how a comprehension of physician values may be helpful in designing effective interventions to improve prescribing. We start with the understanding that physicians have a strong desire to avoid patient-related risks associated with warfarin use. An intervention is designed to sufficiently educate patients to inquire from their physicians about the possible use of warfarin. The simple act of the patient inquiring about this therapeutic option changes the physician's perspective regarding his or her own professional risk and benefit assessment. As a result of a patient inquiring about warfarin, from the prescriber's perspective, there now might be a greater professional risk with not prescribing warfarin and the patient subsequently having a stroke than with prescribing the drug and the patient experiencing a bleeding adverse event. Nothing has changed with regards to the physician's clinical knowledge about the actual risks and benefits of prophylactic warfarin therapy in patients with atrial fibrillation. The only change has been in the physician's perception of professional risk, based on his or her value system to avoid therapeutic failure.
In conclusion, the principle that health care delivery should be evidence based should continue. As such, the need for clinical research that determines the contents of evidence-based practice must grow, as must the programs that can effectively pass that knowledge onto practitioners and patients. But if we are going to improve on practices that are consistently incongruent with the evidence, we need to understand the value systems behind those behaviors and not assume that knowledge is the only limiting factor. We see this line of inquiry as one of the new frontiers for health services research in pharmacotherapy.
